Pages that link to "Q34521744"
Jump to navigation
Jump to search
The following pages link to Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host (Q34521744):
Displaying 38 items.
- Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis (Q28505268) (← links)
- The immunology of Leishmania/HIV co-infection. (Q30428365) (← links)
- Immunomodulation of human monocytes following exposure to Lutzomyia intermedia saliva (Q33327586) (← links)
- Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major (Q33599537) (← links)
- Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. (Q33605647) (← links)
- Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A (Q33768818) (← links)
- Development of a safe live Leishmania vaccine line by gene replacement. (Q33830649) (← links)
- Cutaneous Manifestations of Human and Murine Leishmaniasis (Q33839048) (← links)
- Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis (Q34033888) (← links)
- Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major: inverse relationship to interleukin-12 production (Q34126067) (← links)
- Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice (Q34300949) (← links)
- Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection (Q34443497) (← links)
- The immunology of parasite infections in immunocompromised hosts (Q35029729) (← links)
- Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis (Q35134721) (← links)
- Leishmania and human immunodeficiency virus coinfection: the first 10 years (Q35374078) (← links)
- Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response (Q35448239) (← links)
- Regulatory T cells and parasites (Q35665111) (← links)
- Concomitant Immunity Induced by Persistent Leishmania major Does Not Preclude Secondary Re-Infection: Implications for Genetic Exchange, Diversity and Vaccination (Q36063251) (← links)
- Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection (Q36362701) (← links)
- Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. (Q36363619) (← links)
- Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase (Q36366480) (← links)
- The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. (Q36370082) (← links)
- Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity (Q36399862) (← links)
- Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice (Q36682576) (← links)
- Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion. (Q37080079) (← links)
- Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies. (Q37128771) (← links)
- Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process. (Q37310681) (← links)
- CD4+ T Cells: guardians of the phagosome (Q37712789) (← links)
- Protective immunity and vaccination against cutaneous leishmaniasis. (Q38015852) (← links)
- Post kala-azar dermal leishmaniasis: an unresolved mystery (Q38175646) (← links)
- CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly (Q38387770) (← links)
- Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy. (Q40672553) (← links)
- Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells (Q41115176) (← links)
- The PCR-based detection of Leishmania major in Mus musculus and other rodents caught in southern Iran: a guide to sample selection (Q41982110) (← links)
- The compositional landscape of minicircle sequences isolated from active lesions and scars of American cutaneous leishmaniasis (Q42563822) (← links)
- Experimental murine paracoccidioidomycosis: relationship among the dissemination of the infection, humoral and cellular immune responses (Q43463006) (← links)
- The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis. (Q55408705) (← links)
- Phenotypic and Functional Profiles of Antigen-Specific CD4 and CD8 T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis (Q59795039) (← links)